Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Verona Pharma plc. a U.K.-based clinical stage pharmaceutical company, recently announced positive results from a phase 2 clinical trial testing their compound RPL554. According to the company, the therapy provides ... Read more
Pin It on Pinterest